U.S. Tobacco Stock News

NasdaqGS:BSP
NasdaqGS:BSPSoftware

Is Bending Spoons’ (BSP) Madrid Push Quietly Redefining Its European Talent and Innovation Strategy?

Bending Spoons has recently opened a new office in Madrid’s Recoletos district, its third European base after Milan and London, while offering extensive relocation and commuting support, and actively engaging Spain’s tech community through events, competitions, and scholarships worth more than €1.00 billion across Europe in 2026. By pairing physical expansion in Madrid with large-scale talent initiatives such as the First Ascent Spain retreat and nationwide programming contests, Bending...
NasdaqGS:STRA
NasdaqGS:STRAConsumer Services

Strategic Education (STRA) Could Be 14% Undervalued On Strong Quarterly Results

Why Strategic Education stock is back in focus after its latest quarterly update Strategic Education (STRA) is back on investor radars after reporting higher second quarter and first half 2026 sales and net income, alongside record employer enrollment and margin expansion. See our latest analysis for Strategic Education. The latest earnings, buyback activity and affirmed dividend appear to have supported sentiment around Strategic Education, with the share price at $84.88 and a 90 day share...
NYSE:UHS
NYSE:UHSHealthcare

The Bull Case For Universal Health Services (UHS) Could Change Following Big Q2 Earnings Beat And Buyback Completion - Learn Why

Universal Health Services recently reported past second-quarter 2026 results showing higher sales of US$4,638.01 million and net income of US$358.45 million, and disclosed that between April 1 and June 30, 2026 it repurchased 1,890,000 shares for US$320.3 million. These results also mark the completion of a long-running buyback program totaling about US$6.62 billion and reducing the share count by very large percentage levels, which can meaningfully influence per-share metrics and capital...
NasdaqGS:REPL
NasdaqGS:REPLBiotechs

Replimune Group (REPL) Wins FDA Approval, Is The Valuation Still Too Rich?

Replimune Group (REPL) stock is back in focus after Robbins LLP announced a securities class action tied to the company’s RP1 melanoma program and the U.S. Food and Drug Administration’s April 2026 Complete Response Letter. See our latest analysis for Replimune Group. Investors have been weighing the legal overhang from the RP1 class action against fresh momentum after the FDA granted accelerated approval for TUDRIQEV, with Replimune Group’s share price at $12.06 reflecting a 90 day share...
NYSE:TPC
NYSE:TPCConstruction

Tutor Perini (TPC) Posts Strong Q2 Growth, Is The Stock Still Cheap?

Tutor Perini (TPC) just delivered a busy Q2 2026, with higher revenue and net income, a larger quarterly dividend, active share repurchases, and a new federal infrastructure contract that together drew fresh attention to the stock. See our latest analysis for Tutor Perini. The strong Q2 results, larger dividend, new federal contract and ongoing buybacks have arrived alongside sharp share price momentum for Tutor Perini, with a 30.60% 1 month share price return and a 42.91% year to date share...